ABC
LLY icon

Associated Banc-Corp’s Eli Lilly LLY Stock Holding History

Associated Banc-Corp’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.3M Buy
59,063
+1,027
+2% +$1.04M 1.44% 12
2025
Q4 		$62.4M Buy
58,036
+1,398
+2% +$1.34M 1.6% 13
2025
Q3 		$43.2M Buy
56,638
+1,272
+2% +$947K 1.14% 22
2025
Q2 		$43.2M Buy
55,366
+869
+2% +$675K 1.22% 21
2025
Q1 		$45M Buy
54,497
+3,094
+6% +$2.57M 1.37% 16
2024
Q4 		$39.7M Buy
51,403
+25,104
+95% +$20.8M 1.2% 19
2024
Q3 		$23.3M Buy
26,299
+3,197
+14% +$2.87M 0.68% 42
2024
Q2 		$20.9M Buy
23,102
+2,549
+12% +$2.04M 0.65% 43
2024
Q1 		$16M Buy
20,553
+2,187
+12% +$1.56M 0.51% 56
2023
Q4 		$10.7M Buy
18,366
+1,919
+12% +$1.12M 0.37% 76
2023
Q3 		$8.83M Sell
16,447
-123
-0.7% -$63.4K 0.34% 79
2023
Q2 		$7.77M Sell
16,570
-5
-0% -$2.1K 0.29% 88
2023
Q1 		$5.69M Buy
16,575
+112
+0.7% +$37.8K 0.23% 103
2022
Q4 		$6.02M Sell
16,463
-34
-0.2% -$12.1K 0.25% 101
2022
Q3 		$5.33M Buy
16,497
+30
+0.2% +$9.51K 0.25% 95
2022
Q2 		$5.34M Buy
16,467
+10
+0.1% +$3K 0.23% 100
2022
Q1 		$4.71M Sell
16,457
-30
-0.2% -$7.72K 0.18% 117
2021
Q4 		$4.55M Buy
16,487
+405
+3% +$103K 0.17% 116
2021
Q3 		$3.72M Sell
16,082
-31
-0.2% -$7.65K 0.15% 119
2021
Q2 		$3.7M Sell
16,113
-1,277
-7% -$257K 0.15% 121
2021
Q1 		$2.41M Buy
17,390
+88
+0.5% +$17.2K 0.15% 118
2020
Q4 		$2.92M Buy
17,302
+10
+0.1% +$1.49K 0.11% 144
2020
Q3 		$2.56M Sell
17,292
-333
-2% -$51.5K 0.11% 143
2020
Q2 		$2.89M Sell
17,625
-865
-5% -$133K 0.13% 131
2020
Q1 		$2.56M Buy
18,490
+9,705
+110% +$1.33M 0.14% 129
2019
Q4 		$1.16M Sell
8,785
-505
-5% -$58.5K 0.06% 179
2019
Q3 		$1.04M Buy
9,290
+458
+5% +$51K 0.06% 180
2019
Q2 		$979K Sell
8,832
-229
-3% -$27K 0.05% 184
2019
Q1 		$1.18M Buy
9,061
+142
+2% +$17.3K 0.07% 179
2018
Q4 		$1.03M Sell
8,919
-1,200
-12% -$134K 0.07% 180
2018
Q3 		$1.09M Sell
10,119
-457
-4% -$45.7K 0.06% 180
2018
Q2 		$903K Buy
10,576
+400
+4% +$32.9K 0.05% 186
2018
Q1 		$787K Sell
10,176
-18
-0.2% -$1.45K 0.04% 191
2017
Q4 		$861K Hold
10,194
– – 0.05% 193
2017
Q3 		$871K Sell
10,194
-156
-2% -$12.8K 0.05% 187
2017
Q2 		$852K Buy
10,350
+380
+4% +$31K 0.05% 189
2017
Q1 		$838K Buy
9,970
+100
+1% +$8.01K 0.05% 188
2016
Q4 		$726K Sell
9,870
-622
-6% -$46.3K 0.05% 191
2016
Q3 		$842K Buy
10,492
+76
+0.7% +$6.08K 0.05% 182
2016
Q2 		$820K Sell
10,416
-296
-3% -$22.3K 0.05% 183
2016
Q1 		$771K Sell
10,712
-4
-0% -$303 0.05% 185
2015
Q4 		$903K Buy
10,716
+156
+1% +$12.9K 0.06% 170
2015
Q3 		$884K Buy
10,560
+33
+0.3% +$2.79K 0.06% 174
2015
Q2 		$879K Hold
10,527
– – 0.06% 175
2015
Q1 		$765K Buy
10,527
+1,500
+17% +$107K 0.05% 188
2014
Q4 		$623K Sell
9,027
-475
-5% -$32.1K 0.04% 195
2014
Q3 		$616K Sell
9,502
-600
-6% -$38K 0.04% 196
2014
Q2 		$628K Sell
10,102
-2,882
-22% -$172K 0.04% 195
2014
Q1 		$764K Sell
12,984
-1,208
-9% -$67.4K 0.05% 175
2013
Q4 		$724K Sell
14,192
-1,359
-9% -$68.1K 0.05% 175
2013
Q3 		$783K Buy
15,551
+106
+0.7% +$5.55K 0.06% 172
2013
Q2 		$759K Buy
+15,445
New +$840K 0.06% 160

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Associated Banc-Corp's LLY Position: Q1 2026 in Review

Associated Banc-Corp increased its Eli Lilly (LLY) stake by 1.8% in Q1 2026, buying an estimated $1.04M and bringing the position to 59,063 shares worth $54.3M. The position accounts for 1.44% of the portfolio, ranked #12.

Associated Banc-Corp first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $62.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Associated Banc-Corp held 59,063 shares of Eli Lilly worth $54.3M as of Q1 2026.
  • Associated Banc-Corp bought 1,027 Eli Lilly shares in Q1 2026, an estimated $1.04M.
  • Eli Lilly made up 1.44% of Associated Banc-Corp's portfolio in Q1 2026, its #12 holding.
  • Associated Banc-Corp first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Associated Banc-Corp's Eli Lilly position peaked at $62.4M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.